SSA
OPTN

Schonfeld Strategic Advisors’s OptiNose OPTN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,767
Closed -$27.6K – 2320
2024
Q2 		$27.6K Buy
+1,767
New +$29.6K ﹤0.01% 1988
2018
Q3 		– Sell
-1,413
Closed -$593K – 967
2018
Q2 		$593K Buy
+1,413
New +$476K 0.03% 501

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schonfeld Strategic Advisors's OPTN Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 1,767 shares — an estimated $27.6K sold.

Schonfeld Strategic Advisors first reported a position in OPTN in Q2 2018 and held it in 2 quarters. The position peaked at $593K in Q2 2018. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 1,767 OptiNose shares in Q3 2024, an estimated $27.6K.
  • Schonfeld Strategic Advisors first reported a position in OptiNose in Q2 2018 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's OptiNose position peaked at $593K in Q2 2018.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.